Latest Breaking News On - Thomas taapken - Page 1 : vimarsana.com

Scibase : Postal voting form AGM 2024 - MarketScreener

Scibase : Postal voting form AGM 2024 - MarketScreener
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Pia renaudinJvalini dwarkasingDiana ferroTord lendauMatt leavittSetterwalls advokatbyrEric torstenssonRobert molanderThomas taapkenSwedish companiesScibase holdingSwedish companies act

Scibase : Presentation Board of directors AGM 2024

Scibase : Presentation Board of directors AGM 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Diana ferroThomas taapkenLeo pharmaCopenhagen business schoolMedskin solutions dr suwelackTechnical university of berlinUniversity of hamburgNovo nordiskRadius healthUniversity of california los angelesBurrill coAnnual general meetingCopenhagen businessAscendis pharmaConcert pharmaMedical marketing

Notice to attend the annual general meeting in SciBase Holding AB (publ)

Notice to attend the annual general meeting in SciBase Holding AB (publ)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesPia renaudinSetterwalls advokatbyrPeter elmvikDharminder chahalTord lendauThomas axelssonMagnus lagerbergStockholms elbolagRobert molanderLeo pharmaJvalini dwarkasingEric torstenssonMatt leavittDiana ferroAxel helle

InflaRx N : 20240425_Minutes 2024 AGM - InflaRx NV_signed

MINUTES OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS INFLARX N.V. APRIL 25, 2024 Minutes.

Noord hollandChristian schmidThomas taapkenLeanne meursNiels riedemannCompany dutchNetherlands the companyChief executive officerChief financial officer

InflaRx N : 11-2023-InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update -November 01, 2023 at 09:13 am EDT

Jena, Germany, November 1, 2023 - InflaRx N.V. , a biotechnology company pioneering anti-inflammatory therapeutics targeting the complement system, announced today financial results.

United statesThomas taapkenGerman ministry of educationDevelopment expensesDevelopment of vilobelimabDrug administrationEuropean medicines agencyInflarx stops development of vilobelimabEuropean unionGerman ministry of healthRecent highlightsBusiness updateTopline resultsSingle ascending dosePhasei trial support best in class potentialPyoderma gangrenosum